Sparing Salivary Glands in Head and Neck Cancer Treatment
Author Information
Author(s): Wendt Thomas G, Abbasi-Senger Nasrin, Salz Henning, Pinquart Ines, Koscielny Sven, Przetak Susi-Marie, Wiezorek Tilo
Primary Institution: Friedrich-Schiller-University Jena
Hypothesis
Can 3D-conformal intensity modulated radiotherapy (3D-c-IMRT) with metallic compensators effectively spare the parotid glands during treatment for head and neck cancer?
Conclusion
3D-c-IMRT using metallic compensators achieves effective sparing of the parotid glands in most patients with advanced head and neck cancers.
Supporting Evidence
- The median dose at the parotid gland was restricted to 30 Gy or less in 37 of 39 patients.
- In none of the 17 patients treated with MCP 96 alloy compensators did the parotid gland dose exceed 27.6 Gy.
- Chronic xerostomia was observed in 85% of patients at 6 months post-treatment.
Takeaway
This study shows that a special type of radiation therapy can help protect the salivary glands in patients with head and neck cancer, which helps them avoid dry mouth.
Methodology
39 patients with squamous cell cancer were treated with 3D-c-IMRT, and dose distributions were analyzed for parotid gland sparing and toxicity.
Limitations
The study may not generalize to all head and neck cancer patients as it focused on advanced cases and specific treatment techniques.
Participant Demographics
{"age":{"median":57,"range":"37-76"},"gender_ratio":{"male":35,"female":4},"cancer_sites":{"nasopharynx":4,"oropharynx":20,"oral_cavity":9,"hypopharynx":5,"CUP_syndrome":1}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website